This study evaluates the efficacy of the Neuro+ Attention Training System (Neuro+) in improving attention skills in children. Half of participants will receive the Neuro+ intervention for 10 weeks, while the other half will continue treatment as usual (TAU) for the same period. We expect those receiving the Neuro+ intervention to see significant improvements in ADHD symptoms relative to the TAU controls.
Neuro+ a non-pharmacological intervention that targets the underlying neural signatures and cognitive deficits which are assumed to mediate attention pathways. Targeting those underlying areas could reduce ADHD symptoms and potentially lead to greater transfer and generalization to functioning in the classroom and every day life. Neuro+ combines neurofeedback, biofeedback, and go/no-go training protocols embedded in a training video game to help develop and improve attention skills. The protocols function as follows: Neurofeedback: Users wear a dry, wireless, easy-to-use EEG headset that interfaces with computer software to provide feedback on their level of brain activation, or focus. Users must focus in order to advance through the training game. Motion-biofeedback: Accelerometers in the headset send data on users' movement to the training game, such that users must maintain complete control of their bodies and remain absolutely still in order to advance through the game and avoid costly point penalties. Go/no-go training: To practice impulse control, users will be challenged with adaptive "go/no-go tasks," requiring them to quickly and accurately respond to target stimuli and ignore distractions, with the tasks becoming more difficult as the user improves.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
60
Attention training program with Neuro+ software
Continuation of current ADHD treatment
Neuropsychiatric Clinic at Carolina Partners in Mental HealthCare
Raleigh, North Carolina, United States
Change in ADHD symptoms with Quotient ADHD System assessment
Assessments to be conducted with the Quotient ADHD System
Time frame: At screening and at final clinical visit within 1 week following intervention
Change in assessment of ADHD symptoms with Conners 3-Parent rating scale
Assessments to be conducted with the Conners 3-Parent rating scale
Time frame: At screening and at final clinical visit within 1 week following intervention
Incidence of adverse events
Self-reported incidence of adverse events
Time frame: As reported by subjects at final clinical visit, which occurs within 1 week following intervention.
Self-reported convenience ratings of Neuro+ intervention
As evaluated on a Likert scale, the extent to which subjects and parents found the Neuro+ intervention convenient/easy-to-use
Time frame: At final clinical visit, within 1 week following intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.